Inhaled RPL554 Provides Optimal Delivery for COPD, Other Respiratory Illnesses, Trial Shows
Verona Pharma’s lead investigational medicine RPL554, engineered to treat patients with chronic obstructive pulmonary disease (COPD) and other respiratory disorders, was found to have an effective therapeutic profile when administrated by inhalation to healthy volunteers. This finding resulted from data obtained during a U.S. clinical trial that Verona…